SecBot SecBot
PRESS-RELEASE ·Filed Oct 5, 2026

IRTC

iRhythm
MIXED
Impact 6/10
Horizonmonths Processed21d 7h ago WireGlobeNewswire
Press release · M&A
Actionable Insight ◆ Mixed

Watch the Q3 2026 earnings call on November 5 for updated 2026 guidance incorporating VitalConnect. The key metrics to track are revenue growth acceleration and whether the 15% adjusted EBITDA margin target remains credible post-integration.

DirectionMixed
Confidencehigh
Horizonmonths
Latest settled — T+5d ⚠ clustered
IRTC ▼ -2.21% at T+5d
NEUTRAL call -2.21% · α vs SPY -2.63% · entry $109.09 → $106.68
Next anchor: T+20d in 7d
Latest observation: T+14 +8.78% FF3 residual α
Entry = T+0 close
Oct 5, 2026
via day close
T+1d
-1.73%
call -1.73% · α -2.28%
$107.20
settled 20d ago
T+5d
-2.21%
call -2.21% · α -2.63%
$106.68
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

iRhythm completed its acquisition of VitalConnect for $237.5M in cash plus up to 423,334 shares, adding complementary mobile cardiac telemetry and multi-vitals capabilities. The deal is expected to enhance revenue growth from 2027 while preserving a 15% adjusted EBITDA margin target, but the purchase consideration and integration risks are material.

Key Financial Metrics

Deal Value
$237.5M

Key Facts

  • Acquisition of VitalConnect completed for $237.5M in cash plus up to 423,334 shares
  • iRhythm provided $10.0M working capital funding between signing and closing
  • Deal expected to enhance revenue growth rate beginning in 2027 while preserving 15% adjusted EBITDA margin target for 2027
  • VitalConnect platform offers up to 30-day monitoring, four-in-one functionality, and up to 11 physiological parameters
  • Updated 2026 financial guidance inclusive of VitalConnect to be provided on Q3 earnings call November 5, 2026

Financial Impact

$237.5M cash plus up to 423,334 shares; $10.0M working capital provided

revenueadjusted EBITDA margincash balance

Risk Factors

  • Integration challenges could delay revenue synergies or increase costs
  • Cash consideration of $237.5M reduces balance sheet flexibility
  • Share issuance (up to 423,334 shares) creates modest dilution
  • VitalConnect's MCT market may face competitive pressure

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3374624
23 reports for IRTC
Performance horizon
70% Hit rate @ T+5 7 of 10 directional calls Went positive at some point 8 of 10 best @ T+60▲ +16.85%Feb 25, 2026
Filters
Rows
Reports for IRTC — sortable, filterable
TypeNow
Oct 15, 2026
11d ago
Press Release
NEUTRAL ★ 1/10
$108.66awaiting T+5—$121.93 (+12.21%)
Oct 13, 2026
12d ago
SC 13G/A
NEUTRAL ★ 2/10
$106.05 $113.55▲ +7.07%▲ +6.62%$121.93 (+14.97%)
Oct 5, 2026
21d ago
8-K
BULLISH ★ 6/10
$109.09 $106.68▼ −2.21%▼ −2.63%$121.93 (+11.77%)
Oct 5, 2026
21d ago
Press Release
MIXED ★ 6/10
$109.09 $106.68▼ −2.21%▼ −2.63%$121.93 (+11.77%)
Sep 22, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$111.75 $113.66▲ +1.71%▲ +2.38%$121.93 (+9.11%)
Aug 11, 2026
10w ago
Insider Cluster
BEARISH ★ 5/10
$125.35 $124.75▲ +0.48%▲ +0.03%$121.93 (+2.73%)
Aug 11, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$125.35 $124.75▼ −0.48%▼ −0.03%$121.93 (−2.73%)
Aug 4, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$124.50 $125.35▲ +0.68%▲ +0.33%$121.93 (−2.06%)
Jul 6, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$125.09 $112.55▼ −10.02%▼ −10.58%$121.93 (−2.53%)
Jun 15, 2026
19w ago
8-K
BEARISH ★ 6/10
$108.84 $110.12▼ −1.18%▼ −3.41%$121.93 (−12.03%)
Showing 10 of 23

US Market Status

Market Closed — Opens Tue (16h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 5, 2026